Search research articles
Contact Us
Filters
Showing results (31-40 of 105) with videos related to
Page
of 11
Sort By:
Biochemistry
|
July 21, 1992
Bis-ANS as a specific inhibitor for microtubule-associated protein induced assembly of tubulin
M Mazumdar, P K Parrack, K Mukhopadhyay, et al.
American Journal of Epidemiology
|
October 1, 1972
Long-term trends in perinatal deaths among offspring of mothers with previous child losses
E R Schlesinger, S M Mazumdar, V M Logrillo
European Journal of Medicinal Chemistry
|
March 29, 2008
Design and synthesis of bisubstrate inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: overview and perspectives
D Fournier, D Poirier, M Mazumdar, et al.
Journal of Neuroendocrinology
|
April 25, 2006
Reproduction phase-related expression of beta-endorphin-like immunoreactivity in the nucleus lateralis tuberis of the female Indian major carp Cirrhinus mrigala: correlation with the luteinising hormone cells-ovary axis
A J Sakharkar, P S Singru, M Mazumdar, et al.
Neuron
|
May 1, 1993
Molecular cloning of the retrograde transport motor cytoplasmic dynein (MAP 1C)
A Mikami, B M Paschal, M Mazumdar, et al.
Journal of the National Cancer Institute
|
September 7, 2000
Calvert's formula for dosing carboplatin: overview and concerns of applicability in high-dose setting
M Mazumdar, A Smith, W P Tong, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 25, 1996
In vitro motility from recombinant dynein heavy chain
M Mazumdar, A Mikami, M A Gee, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas
|
January 1, 1992
Virulence of nonpathogenic zymodemes of Entamoeba histolytica isolates from asymptomatic subjects in Calcutta, India
R M Mukherjee, M Mazumdar, T K Maitra, et al.
Investigational New Drugs
|
September 20, 2001
Phase II trial of irofulven (6-hydroxymethylacylfulvene) for patients with advanced renal cell carcinoma
W J Berg, L Schwartz, R Yu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1992
Infiltrating breast carcinoma in patients age 30 years and younger: long term outcome for life, relapse, and second primary tumors
C G Lee, B McCormick, M Mazumdar, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 105) with videos related to
Sort By:
Page
of 11
Biochemistry
|
July 21, 1992
Bis-ANS as a specific inhibitor for microtubule-associated protein induced assembly of tubulin
M Mazumdar, P K Parrack, K Mukhopadhyay, et al.
American Journal of Epidemiology
|
October 1, 1972
Long-term trends in perinatal deaths among offspring of mothers with previous child losses
E R Schlesinger, S M Mazumdar, V M Logrillo
European Journal of Medicinal Chemistry
|
March 29, 2008
Design and synthesis of bisubstrate inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: overview and perspectives
D Fournier, D Poirier, M Mazumdar, et al.
Journal of Neuroendocrinology
|
April 25, 2006
Reproduction phase-related expression of beta-endorphin-like immunoreactivity in the nucleus lateralis tuberis of the female Indian major carp Cirrhinus mrigala: correlation with the luteinising hormone cells-ovary axis
A J Sakharkar, P S Singru, M Mazumdar, et al.
Neuron
|
May 1, 1993
Molecular cloning of the retrograde transport motor cytoplasmic dynein (MAP 1C)
A Mikami, B M Paschal, M Mazumdar, et al.
Journal of the National Cancer Institute
|
September 7, 2000
Calvert's formula for dosing carboplatin: overview and concerns of applicability in high-dose setting
M Mazumdar, A Smith, W P Tong, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 25, 1996
In vitro motility from recombinant dynein heavy chain
M Mazumdar, A Mikami, M A Gee, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas
|
January 1, 1992
Virulence of nonpathogenic zymodemes of Entamoeba histolytica isolates from asymptomatic subjects in Calcutta, India
R M Mukherjee, M Mazumdar, T K Maitra, et al.
Investigational New Drugs
|
September 20, 2001
Phase II trial of irofulven (6-hydroxymethylacylfulvene) for patients with advanced renal cell carcinoma
W J Berg, L Schwartz, R Yu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1992
Infiltrating breast carcinoma in patients age 30 years and younger: long term outcome for life, relapse, and second primary tumors
C G Lee, B McCormick, M Mazumdar, et al.
Page
of 11